<DOC>
	<DOCNO>NCT00247715</DOCNO>
	<brief_summary>The purpose study determine treatment strategy , step-up step-down treatment strategy , cost-effective treatment patient new onset dyspepsia primary care .</brief_summary>
	<brief_title>Comparison `` Step-Up '' Versus `` Step-Down '' Treatment Strategy Patients With New Onset Dyspepsia General Practice ( The DIAMOND-Study )</brief_title>
	<detailed_description>Dyspepsia common population . On annual basis , 20 % -40 % general population suffers upper gastrointestinal symptom . The prevalence dyspepsia present primary care 3 % , average 24 % patient refer secondary care year . In spite consensus statement guideline , effective treatment strategy manage dyspepsia primary care remain determined . In 2000 Health Council Netherlands publish advice Minister Health , Welfare Sport special consideration cost-effective strategy management dyspepsia . The Health Counsel Committee agree general exist guideline Dutch College General Practitioners start empirical treatment . However , committee conclude research necessary management dyspepsia primary care , especially uninvestigated patient research conduct patient persistent dyspeptic symptom refer secondary care . Comparison : In study empirical treatment accord exist guideline Dutch College General Practitioners ( step-up treatment strategy ) compare step-down treatment strategy . According step-down treatment strategy patient begin treatment proton pomp inhibitor , expensive acid-suppressor often prescribed general practitioner . Step-up strategy : Algeldrate-magnesium oxide , case persisting/relapsing symptom continue ranitidine , necessary continue pantoprazole . Step-down strategy : Pantoprazole , case persist relapse symptom continue ranitidine , necessary continue algeldrate-magnesium oxide .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<mesh_term>Histamine H2 Antagonists</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<criteria>Presence new episode dyspepsia , define episodic persistent symptom include abdominal pain discomfort , opinion general practitioner , referable upper gastrointestinal tract . Over 18 year age Informed consent ( write ) give . Use prescribed acid suppressive medication 3 month consult Investigated upper gastrointestinal endoscopy one year inclusion Malignancy Contraindication study medication Pregnancy Alarming symptom like weight loss , bleeding , disturb food passage Patients insufficient comprehension Dutch language</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>uninvestigated dyspepsia</keyword>
	<keyword>cost effectiveness</keyword>
	<keyword>acid suppressive medicine</keyword>
	<keyword>primary care</keyword>
	<keyword>gastrointestinal complaint</keyword>
	<keyword>Gastrointestinal drug</keyword>
</DOC>